162 related articles for article (PubMed ID: 22136157)
1. Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital.
Rémy H; Coulot J; Borget I; Ricard M; Guilabert N; Lavielle F; Camps E; Baudin E; Lumbroso J; Leboulleux S; Schlumberger M
Thyroid; 2012 Jan; 22(1):59-63. PubMed ID: 22136157
[TBL] [Abstract][Full Text] [Related]
2. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
[TBL] [Abstract][Full Text] [Related]
3. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
4. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
5. Potential third-party radiation exposure from patients undergoing therapy with 131I for thyroid cancer or metastases.
D'Alessio D; Giliberti C; Benassi M; Strigari L
Health Phys; 2015 Mar; 108(3):319-25. PubMed ID: 25627943
[TBL] [Abstract][Full Text] [Related]
6. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A
Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825
[TBL] [Abstract][Full Text] [Related]
7. A practical guideline for the release of patients treated by I-131 based on Monte Carlo dose calculations for family members.
Han EY; Lee C; Mcguire L; Bolch WE
J Radiol Prot; 2014 Jun; 34(2):N7-17. PubMed ID: 24705486
[TBL] [Abstract][Full Text] [Related]
8. Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions.
Yoshimura M; Tsutsui H; Ikeda N; Koizumi K
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):101-8. PubMed ID: 23474638
[TBL] [Abstract][Full Text] [Related]
9. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
10. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
[TBL] [Abstract][Full Text] [Related]
11. An engagement factor for caregiver radiation dose assessment with radioiodine treatment.
Lee HK; Hong SJ; Jeong KH; Jung JW; Kim SM; Kang YH; Han MS
Radiat Prot Dosimetry; 2015 Mar; 163(4):499-508. PubMed ID: 25028695
[TBL] [Abstract][Full Text] [Related]
12. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study on the transition of radiation dose rate and iodine distribution in patients with I-131-treated well-differentiated thyroid cancer to improve bed control shorten isolation periods.
Yama N; Sakata K; Hyodoh H; Tamakawa M; Hareyama M
Ann Nucl Med; 2012 Jun; 26(5):390-6. PubMed ID: 22382609
[TBL] [Abstract][Full Text] [Related]
14. Measurement of radiation exposure in relatives of thyroid cancer patients treated with (131)I.
Ramírez-Garzón YT; Ávila O; Medina LA; Gamboa-deBuen I; Rodríguez-Laguna A; Buenfil AE; Ruíz-Trejo C; Estrada E; Brandan ME
Health Phys; 2014 Nov; 107(5):410-6. PubMed ID: 25271931
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
16. Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
Taïeb D; Sebag F; Farman-Ara B; Portal T; Baumstarck-Barrau K; Fortanier C; Bourrelly M; Mancini J; De Micco C; Auquier P; Conte-Devolx B; Henry JF; Mundler O
J Clin Endocrinol Metab; 2010 Jul; 95(7):3283-90. PubMed ID: 20392868
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a card with instructions for patients treated for thyroid carcinoma with 131I.
Mínguez P; Genolla J; Fombellida JC
Radiat Prot Dosimetry; 2012 Aug; 151(1):76-80. PubMed ID: 22232772
[TBL] [Abstract][Full Text] [Related]
18. Uptake of ¹³¹I in households of thyroid cancer patients.
North DL
Health Phys; 2013 Apr; 104(4):434-6. PubMed ID: 23439148
[TBL] [Abstract][Full Text] [Related]
19. EVALUATION OF THE RELEASE CRITERIA FROM HOSPITAL OF THYROID CARCINOMA PATIENT TREATED WITH 131I.
Lahfi Y; Anjak O
Radiat Prot Dosimetry; 2016 Dec; 171(4):534-538. PubMed ID: 26590393
[TBL] [Abstract][Full Text] [Related]
20. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131.
Cappelen T; Unhjem JF; Amundsen AL; Kravdal G; Følling I
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):81-6. PubMed ID: 16151768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
